Telmisar/Telmisar 80 Dosage/Direction for Use

Route of Administration: Oral.
Treatment of Essential Hypertension: The usually effective dose is 40 mg once daily. Some patients may already benefit at a daily dose of 20 mg. In cases where the target blood pressure is not achieved, the dose of Telmisartan can be increased to a maximum of 80 mg once daily. Alternatively, Telmisartan may be used in combination with thiazide-type diuretics such as hydrochlorothiazide, which has been shown to have an additive blood pressure lowering effect with Telmisartan. When considering raising the dose, it must be borne in mind that the maximum antihypertensive effect is generally attained four to eight weeks after the start of treatment.
Cardiovascular Prevention: The recommended dose is 80 mg once daily. It is not known whether doses lower than 80 mg of Telmisartan are effective in reducing cardiovascular morbidity.
When initiating Telmisartan therapy for the reduction of cardiovascular morbidity, close monitoring of blood pressure is recommended, and if appropriate adjustment of medications that lower blood pressure may be necessary. Telmisartan may be taken with or without food.
Special Patient Populations: Renal Impairment: No posology adjustment is required for patients with mild to moderate renal impairment. Limited experience is available in patients with severe renal impairment or haemodialysis. A lower starting dose of 20 mg is recommended in these patients.
Hepatic impairment: In patients with mild to moderate hepatic impairment, the posology should not exceed 40 mg once daily.
Elderly: No dose adjustment is necessary for elderly patients.
Paediatric Patients: Telmisartan is not recommended for use in children below 18 years due to a lack of data on safety and efficacy.